Carlie Faye Moore, age 73, of Gamaliel, Kentucky, passed away peacefully on Saturday, December 27, 2025, at his home. Carlie ...

If Thursday night was the last game Travis Kelce played inside Arrowhead Stadium, he sure tried to make it a memorable one.

The 59ers' 3-4 start to the season features plenty of inconsistencies. Andrean isn't short for talent, though — at this point ...

The 2025 deer hunting season will come to an end in one week on Dec. 31. While the firearm and muzzleloader seasons have ...

This article has been revised and clarified. Pasadena-based biopharma company Arrowhead Pharmaceuticals Inc. had a double-dose of good news last month. On Nov. 18, Arrowhead announced that it had ...

Arrowhead Game Studios has already begun work on its next game, but how does a developer follow a galactic success as beloved as Helldivers 2? Former CEO and current CCO Johan Pilestedt says whatever ...

With a fresh FDA endorsement for its drug plozasiran, California-based Arrowhead Pharmaceuticals has successfully broken through to the commercial realm. Complicating the matter, however, is the fact ...

At first, archaeologist Andrei Krivoshapkin and his colleagues thought the small, pointed stone shards they were uncovering were just a curiosity. Krivoshapkin and his team were digging deep into ...

The Chiefs continue to move toward an inevitable decision between renovating Arrowhead Stadium and building a new stadium. On Monday, Chiefs owner Clark Hunt addressed the status of the team’s effort ...

Arrowhead Pharmaceuticals has seen its consensus analyst price target increase from $45 to $47.50 per share, reflecting growing confidence in the company's strategy and market positioning. This ...

Pasadena-based Arrowhead Pharmaceuticals Inc. has announced another major licensing deal with a pharma giant. This one is with Basel, Switzerland-based Novartis for $200 million in upfront payment and ...